Jim Simons's position in C4 Therapeutics is currently worth $3.71M. That's 0.01% of their equity portfolio (1526th largest holding). The first C4 Therapeutics trade was made in Q4 2021. Since then Jim Simons bought shares nine more times and sold shares on eight occasions. The stake costed the investor $2.48M, netting the investor a gain of 50% so far.